Reprints
A single copy of this article may be reprinted for personal, noncommercial use only.
Fosamax and other bisphosphonates: Unusual risks?
By Mayo Clinic staffOriginal Article: http://www.mayoclinic.com/health/fosamax/AN01379
- With Mayo Clinic endocrinologist
Kurt A. Kennel, M.D.
Risk factors (1)
- High-protein diets: Are they safe?
Treatments and drugs (3)
- Osteoporosis medications: Must they be taken indefinitely?
- Osteoporosis and long-term prednisone: What is the risk?
- Fosamax and other bisphosphonates: Unusual risks?
Prevention (3)
- Calcium supplements: When should they be taken?
- Chocolate: Does it impair calcium absorption?
- Elliptical machines: Better than treadmills?
Free
E-newsletter
Subscribe to Housecall
Our weekly general interest
e-newsletter keeps you up to date
on a wide variety of health topics.
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Question
Fosamax and other bisphosphonates: Unusual risks?
How serious are the risks of bisphosphonates, such as alendronate (Fosamax) and risedronate (Actonel), when taken for osteoporosis? Can they actually cause additional bone problems?
Answer
from Kurt A. Kennel, M.D.
Like all drugs, bisphosphonates have risks as well as benefits. For well over a decade, though, doctors have prescribed bisphosphonates to millions of people, very few of whom developed major side effects.
Still, reports of an association between bisphosphonate use and two rare but serious problems — osteonecrosis of the jaw and a specific type of fracture in the long bone of the leg (femur) — have raised concerns. Osteonecrosis of the jaw develops when the jaw bone fails to heal after a minor injury — for example, the type of injury sometimes caused by getting a tooth pulled.
A clear cause-and-effect relationship between bisphosphonate use and jaw osteonecrosis remains unproved. The best estimate of risk is 0.1 percent, meaning the condition occurs in 1 out of every 1,000 women taking bisphosphonates over the course of a year. The risk of a bisphosphonate-related leg fracture seems to be much lower than that of jaw osteonecrosis.
Overall, bisphosphonates are more likely to help you by preventing fractures than to hurt you by causing jaw problems or unusual femur fractures. This is particularly true for women with postmenopausal osteoporosis.
Next questionCalcium supplements: When should they be taken?
- Khosla S, et al. Benefits and risks of bisphosphonate therapy for osteoporosis. Journal of Endocrinology and Metabolism. 2012;97:2272.
- Haworth A, et al. Skeletal complications of bisphosphonate use: what the radiologist should know. The British Journal of Radiology. 2012; 85:1333.
- Ruggiero SL, et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws — 2009 Update. Journal of Oral and Maxillofacial Surgery. 2009;67(supp1):2-12.
- Schilcher J, et al. Bisphosphonate use and atypical fractures of the femoral shaft. New England Journal of Medicine. 2011;364:1728.
- AskMayoExpert. What is the risk of jaw osteonecrosis with the use of bisphosphonates for treatment of osteoporosis? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
- Hellstein JW, et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: Executive summary of recommendations from the American Dental Association Council on Scientific Affairs. Journal of the American Dental Association. 2011;142:1243.
- AskMayoExpert. Do bisphosphonates cause unusual fractures in patients with osteoporosis? Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2012.
Find Mayo Clinic on